er et al,514 144 lesions in 114 patients were treated,
including 117 undergoing primary stenting for symptomatic arch lesions. The authors reported a technical success rate of 94% and no stroke or death at 30 days. At
a mean follow-up of 52 months, symptom-free survival
was 95% and 78% at 12 and 60 months, respectively.514